
Extendicare closes $200-million private placement
Extendicare closes $200-million private placement

Extendicare closes $200-million private placement
MyndTec Inc. Completes Eighth Tranche of Non-Brokered Private Placement
Microbix to provide QAPs to Seegene for HPV assays
Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14
Tempramed signs exclusive Turkish distribution deal
KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUEBEC-UNIVERSITE LAVAL FOR THE DEPLOYMENT OF MEDHERIZE
Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
Pharmather closes sale of ketamine ANDA
Pangea's Amino Innovations launches wholesale program
DiagnosTear Announces Clinical Study with AlyaTec to Advance Analytical Validation and FDA Submission Pathway of TeaRx(TM) Red Eye Diagnostic Test
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market
PharmaTher Closes Sale of Ketamine ANDA, Sharpening Focus on Long-Acting Injectable Ketamine Franchise
Hemostemix to Attend DFCon San Antonio and Closed its Private Placement
Rocket Doctor AI Announces Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth